A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlaxoSmithKline Consumer Healthcare Holdings US Seeks Patent for System and Method for Dental Image Acquisition and Recognition of Early Enamel Erosions of the Teeth
Published: November 25, 2023 by Medical Patent News
Glaxosmithkline Biologicals Submits Patent Application for Sars Cov-2 Spike Protein Construct
Published: November 22, 2023 by Biotechnology Patent News
GSK plans Phase 3 trials for low carbon version of Ventolin inhaler that could cut its greenhouse gas emissions by 90%; the inhaler, prescribed to around 35 million patients, accounts for nearly half of GSK's carbon footprint
Published: November 21, 2023 by U.S. Markets (Alternative Disclosure) via PUBT
INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED FILES APPLICATION FOR "METHOD FOR INACTIVATION OF SARS-COV-2"
Published: November 20, 2023 by U.S. Fed News
GSK obtains exclusive worldwide rights to develop and commercialize JNJ-3989 from Janssen; JNJ-3989 is a small interfering ribonucleic acid therapeutic potential treatment for chronic hepatitis B that Janssen had licensed from Arrowhead Pharmaceuticals
Published: November 13, 2023 by M2 PressWIRE

Ask us about our Beauty & Personal Care market view

Trending Chart

Interactive chart with headline count